Supply Issues Typhoo Tea Ltd Tea Bags ACT307 (ICN 2846)

• The supply issue with tea bags from Typhoo Tea Ltd is now resolved.
• ACT307 is now available to order through our online catalogue.
• This ICN is now closed.

• The supply issue with tea bags from Typhoo Tea Ltd is continuing.
• One product code remains affected:
  • ACT307 – Tea bags
• The affected product remains suspended and unavailable to order.
• Potential indirect alternative products are available to order through our online catalogue for the affected products.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternative.
• The supply issue is anticipated to be resolved by 15 June 2025.

Change:

• The supplier Typhoo Tea Ltd has informed us of a supply issue with its case of 440 Tea Bags.
• One product code is affected:
  • ACT307 – Tea bags Typhoo 440s RFA.
• The supply issue is due to supplier manufacturing issues.

Impact:

• The affected product code is currently available whilst stocks last, once depleted it will be unavailable to order.
• A potential indirect alternative product is available to order through our online catalogue:
  • ACT85006 – Tea bags 1100s.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternative.
• The supply issue is anticipated to be resolved by 30 April 2025.

Next Steps:              

• Customers are advised to log into our website to view the potential indirect alternative product.
• Please note, the pack size of the alternative is a case of 1100 tea bags.
• The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.